Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EPRT stock price vs CLX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CLX's multiple
Needs CLX P/E.
Implied fair value · at EPRT's multiple
Needs EPRT P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Essential Properties Realty Trust, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
THE CLOROX COMPANY · implied price per share
Bear
$47.21
Base
$55.41
Bull
$69.96
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
REALTY INCOME CORP
EPRT vs O
AGREE REALTY CORP
EPRT vs ADC
LTC PROPERTIES INC
EPRT vs LTC
Four Corners Property Trust, Inc.
EPRT vs FCPT
Procter & Gamble Company
EPRT vs PG
COLGATE PALMOLIVE CO
EPRT vs CL
CHURCH & DWIGHT CO INC /DE/
EPRT vs CHD
KIMBERLY CLARK CORP
EPRT vs KMB
ECOLAB INC.
EPRT vs ECL
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe EPRT’s 24.8% revenue growth and superior margins can persist long enough to justify 24.4x earnings and 16.4x EV/revenue, then hold or accumulate on weakness; otherwise, the current valuation looks stretched versus both CLX and EPRT’s DCF range, arguing for caution.
On the supplied P/E basis, EPRT’s implied price of $19.09 sits 38.8% below the current price of $31.18, indicating the stock appears overvalued relative to CLX benchmark. However, EPRT also trades above CLX-implied range of $4.30-$17.45 and within its own historical band of $28.06-$34.30, which suggests the gap is partly a function of CLX-multiple normalization rather than a clear dislocation.
Supporting Metrics
